ASH VTE Guidelines: Prevention and Treatment in Patients with Cancer
Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk of morbidity and mortality. These guidelines are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of VTE in patients with cancer.
Access the full guidelines on the Blood Advances website:
Guideline Implementation Tools and Resources
ASH guidelines are reviewed annually by expert work groups convened by ASH. Resources derived from guidelines that require updating are removed from the ASH website.
VTE Guidelines: What You Should Know
This one-page snapshot provides a high-level summary of the guidelines on the prevention and treatment of VTE in patients with cancer. A snapshot of the full VTE guidelines is also available for download.
ASH Clinical Practice Guidelines App
The ASH Clinical Practice Guidelines App provides easy access to every recommendation from all guidelines published by ASH, including rationale for each recommendation, benefits and harms associated with each recommended course of action, and links to the complete evidence-to-decision tables used to develop the recommendations. This app is also available via web interface.
ASH has developed a series of brief, evidence-based pocket guides to help physicians provide quality care to patients. The pocket guides are available via the ASH Pocket Guides App for IOS and Android devices. This app is also available via web interface.
Help your colleagues diagnose, manage, and treat VTE with the following teaching slides designed for easy dissemination: